{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:20:37Z","timestamp":1790079637485,"version":"4.0.1"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejca.2026.116924","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:08:19Z","timestamp":1783379299000},"page":"116924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Management of critically ill cancer patients. Expert consensus statement of the \u201cIntensive Care for Hematology and Oncology Patients\u201d (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (\u00d6GIAIN)"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1650-0048","authenticated-orcid":false,"given":"Asterios","family":"Tzalavras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"B\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Beutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brueder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-6452","authenticated-orcid":false,"given":"Nina","family":"Buchtele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1927-3514","authenticated-orcid":false,"given":"Dennis A.","family":"Eichenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garcia Borrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Hammersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn-Thore","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6266-0512","authenticated-orcid":false,"given":"Stefan","family":"Hatzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2298-2510","authenticated-orcid":false,"given":"Hans-Guido","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kharazipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Kiehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kn\u00f6bl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kochanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schellongowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Stemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-5332","authenticated-orcid":false,"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherina","family":"Lueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"10.1016\/j.ejca.2026.116924_bib2","first-page":"850","article-title":"Intensive care management of cancer patients","volume":"147","author":"B\u00f6ll","year":"2022","journal-title":"Dtsch Med Wochenschr 1946"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00063-019-0594-3","article-title":"Prevalence of cancer patients in German intensive care units","volume":"115","author":"Kochanek","year":"2020","journal-title":"Med Klin Intensivmed Notf"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","article-title":"Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data","volume":"45","author":"Darmon","year":"2019","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4143\/crt.2018.360","article-title":"Improved Survival of Cancer Patients Admitted to the Intensive Care Unit between 2002 and 2011 at a U.S. Teaching Hospital","volume":"51","author":"Sauer","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ejca.2026.116924_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcrc.2020.01.027","article-title":"One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective study","volume":"57","author":"Borcoman","year":"2020","journal-title":"J Crit Care"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","article-title":"Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study","volume":"47","author":"Zampieri","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejca.2026.116924_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the Core GRADE approach","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib10","first-page":"19","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00277-018-3312-y","article-title":"Consensus statement for cancer patients requiring intensive care support","volume":"97","author":"Kiehl","year":"2018","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13613-021-00968-5","article-title":"Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment","volume":"11","author":"Vigneron","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49219-6","article-title":"Prognostic and risk factor analysis of cancer patients after unplanned ICU admission: a real-world multicenter study","volume":"13","author":"Wei","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3892\/ol.2023.14112","article-title":"Prognostic factors in oncological patients with solid tumours requiring intensive care unit admission","volume":"26","author":"Bosch-Compte","year":"2023","journal-title":"Oncol Lett"},{"issue":"22","key":"10.1016\/j.ejca.2026.116924_bib15","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/cancers17223636","article-title":"When and for Whom Does Intensive Care Unit Admission Change the Prognosis in Oncology?-A Scoping Review","volume":"17","author":"Codru","year":"2025","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib16","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1097\/CCM.0000000000002589","article-title":"Characteristics and Outcome of Cancer Patients Admitted to the ICU in England, Wales, and Northern Ireland and National Trends Between 1997 and 2013","volume":"45","author":"Ostermann","year":"2017","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib17","first-page":"730","article-title":"Characterisation and Outcomes of Patients with Solid Organ Malignancies Admitted to the Intensive Care Unit: Mortality and Impact on Functional Status and Oncological Treatment","volume":"14","author":"Garc\u00eda de Herreros","year":"2024","journal-title":"Diagn Basel Switz"},{"issue":"22","key":"10.1016\/j.ejca.2026.116924_bib18","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium\u2014A Groupe de Recherche Respiratoire en R\u00e9animation Onco-H\u00e9matologique Study","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00134-024-07349-z","article-title":"Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study","volume":"50","author":"Munshi","year":"2024","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00063-016-0202-8","article-title":"[Limits of the meaningfulness of intensive care medicine: Position paper of the Ethics Section of DIVI]","volume":"111","author":"Neitzke","year":"2016","journal-title":"Med Klin Intensivmed Notf"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252771","article-title":"Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study","volume":"16","author":"van der Zee","year":"2021","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.ejca.2026.116924_bib22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jgo.2022.08.006","article-title":"Frailty and clinical outcomes in critically ill patients with cancer: A cohort study","volume":"13","author":"Osatnik","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00432-018-2581-0","article-title":"Clinical characteristics and outcomes of cancer patients requiring intensive care unit admission: a prospective study","volume":"144","author":"Martos-Ben\u00edtez","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2026.116924_bib24","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1002\/cncr.32397","article-title":"Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission","volume":"125","author":"Slavin","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-023-01172-3","article-title":"Characteristics and outcomes of patients with acute myeloid leukemia admitted to intensive care unit with acute respiratory failure: a post-hoc analysis of a prospective multicenter study","volume":"13","author":"Secreto","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"9","key":"10.1016\/j.ejca.2026.116924_bib26","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00134-018-5347-x","article-title":"Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients","volume":"44","author":"Lueck","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib27","first-page":"323","article-title":"Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?","volume":"29","author":"Kalici\u0144ska","year":"2021","journal-title":"Support Care Cancer J Multinatl Assoc Support Care Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3904\/kjim.2024.054","article-title":"Short-term and long-term outcomes of critically ill patients with solid malignancy: a retrospective cohort study","volume":"39","author":"Lee","year":"2024","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-024-01366-3","article-title":"Factors associated with cancer treatment resumption after ICU stay in patients with solid tumors","volume":"14","author":"Benguerfi","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib30","first-page":"496","article-title":"Critical care of patients with cancer","volume":"66","author":"Shimabukuro-Vornhagen","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra2104669","article-title":"Outcomes after Critical Illness","volume":"388","author":"Herridge","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.CCM.0000256846.27192.7A","article-title":"The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation","volume":"35","author":"Lecuyer","year":"2007","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.ejca.2026.116924_bib33","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1007\/s00134-024-07579-1","article-title":"European Society of Intensive Care Medicine guidelines on end of life and palliative care in the intensive care unit","volume":"50","author":"Kesecioglu","year":"2024","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamaoncol.2015.3336","article-title":"Time-Limited Trials of Intensive Care for Critically Ill Patients With Cancer: How Long Is Long Enough?","volume":"2","author":"Shrime","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116924_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcrc.2020.10.008","article-title":"Impact of early ICU admission on outcome of critically ill and critically ill cancer patients: A systematic review and meta-analysis","volume":"61","author":"Hourmant","year":"2021","journal-title":"J Crit Care"},{"issue":"9","key":"10.1016\/j.ejca.2026.116924_bib36","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00277-018-3320-y","article-title":"Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence","volume":"97","author":"Orvain","year":"2018","journal-title":"Ann Hematol"},{"issue":"17","key":"10.1016\/j.ejca.2026.116924_bib37","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.3390\/cancers14174266","article-title":"Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores","volume":"14","author":"De Voeght","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib38","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/CCM.0000000000000989","article-title":"Effect of Early Intervention on Long-Term Outcomes of Critically Ill Cancer Patients Admitted to ICUs","volume":"43","author":"Lee","year":"2015","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00277-023-05205-6","article-title":"Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center study","volume":"102","author":"Desprez","year":"2023","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-019-0587-7","article-title":"Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients","volume":"9","author":"Peyrony","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ejca.2026.116924_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcrc.2020.10.022","article-title":"Impact of early ICU admission for critically ill cancer patients: Post-hoc analysis of a prospective multicenter multinational dataset","volume":"62","author":"Hourmant","year":"2021","journal-title":"J Crit Care"},{"issue":"8","key":"10.1016\/j.ejca.2026.116924_bib42","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3109\/10428194.2012.753446","article-title":"Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure","volume":"54","author":"Mokart","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"27","key":"10.1016\/j.ejca.2026.116924_bib43","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1200\/JCO.2016.66.9549","article-title":"Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care Units","volume":"34","author":"Soares","year":"2016","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CCM.0b013e31822d74ba","article-title":"Impact of case volume on survival of septic shock in patients with malignancies","volume":"40","author":"Zuber","year":"2012","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1183\/09031936.00142907","article-title":"Case volume and mortality in haematological patients with acute respiratory failure","volume":"32","author":"Lecuyer","year":"2008","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/bja\/aer449","article-title":"Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study","volume":"108","author":"Bird","year":"2012","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib47","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3906\/sag-2012-107","article-title":"Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?","volume":"51","author":"Aygencel","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib48","doi-asserted-by":"crossref","first-page":"78.e1","DOI":"10.1016\/j.bbmt.2020.09.035","article-title":"Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study","volume":"27","author":"Munshi","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib49","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-016-4330-7","article-title":"Guidelines for the withdrawal of life-sustaining measures","volume":"42","author":"Downar","year":"2016","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1049909113518269","article-title":"Factors associated with futile end-of-life intensive care in a cancer hospital","volume":"32","author":"Cruz","year":"2015","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1049909116682470","article-title":"Earlier Goals of Care Discussions in Hospitalized Terminally Ill Patients and the Quality of End-of-Life Care: A Retrospective Study","volume":"35","author":"Gieniusz","year":"2018","journal-title":"Am J Hosp Palliat Care"},{"issue":"12","key":"10.1016\/j.ejca.2026.116924_bib52","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/CCM.0000000000004016","article-title":"Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial","volume":"47","author":"Ma","year":"2019","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1634\/theoncologist.2016-0227","article-title":"Early Palliative Care Reduces End-of-Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced Cancer","volume":"22","author":"Romano","year":"2017","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib54","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","article-title":"Critical illness in patients with hematologic malignancy: a population-based cohort study","volume":"47","author":"Ferreyro","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","article-title":"An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline","volume":"209","author":"Qadir","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejca.2026.116924_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib57","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/CCM.0000000000001613","article-title":"Impact of Initial Ventilatory Strategy in Hematological Patients With Acute Respiratory Failure: A Systematic Review and Meta-Analysis*","volume":"44","author":"Amado-Rodr\u00edguez","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejca.2026.116924_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcrc.2016.11.042","article-title":"Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: Trends in use and outcome","volume":"38","author":"Neuschwander","year":"2017","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib59","first-page":"25","article-title":"[S3 Guideline: Treating Chronic Respiratory Failure with Non-invasive Ventilation]","volume":"79","author":"Stanzel","year":"2025","journal-title":"Pneumol Stuttg Ger"},{"issue":"8","key":"10.1016\/j.ejca.2026.116924_bib60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2213-2600(16)30093-5","article-title":"Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial","volume":"4","author":"Frat","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"16","key":"10.1016\/j.ejca.2026.116924_bib61","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2015.12402","article-title":"Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial","volume":"314","author":"Lemiale","year":"2015","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejca.2026.116924_bib62","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"issue":"23","key":"10.1016\/j.ejca.2026.116924_bib63","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib64","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3906\/sag-2007-228","article-title":"The use of high-flow nasal oxygen vs. standard oxygen therapy in hematological malignancy patients with acute respiratory failure in hematology wards","volume":"51","author":"Alptekino\u011flu Mendil","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"20","key":"10.1016\/j.ejca.2026.116924_bib65","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2018.14282","article-title":"Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial","volume":"320","author":"Azoulay","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib66","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S2213-2600(22)00096-0","article-title":"High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial","volume":"10","author":"Coudroy","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-022-01069-7","article-title":"Helmet noninvasive support for acute hypoxemic respiratory failure: rationale, mechanism of action and bedside application","volume":"12","author":"Cesarano","year":"2022","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.202009-3575OC","article-title":"Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis","volume":"204","author":"Dumas","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.202103-0813ED","article-title":"Immunocompromised Patients with Acute Respiratory Failure: \u201cDon\u2019t Wait to Intubate\u201d?","volume":"204","author":"Pickkers","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ejca.2026.116924_bib70","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s00134-020-06248-3","article-title":"ECMO for severe ARDS: systematic review and individual patient data meta-analysis","volume":"46","author":"Combes","year":"2020","journal-title":"Intensive Care Med"},{"issue":"21","key":"10.1016\/j.ejca.2026.116924_bib71","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N Engl J Med"},{"issue":"9698","key":"10.1016\/j.ejca.2026.116924_bib72","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","article-title":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial","volume":"374","author":"Peek","year":"2009","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/cc13701","article-title":"Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure","volume":"18","author":"Wohlfarth","year":"2014","journal-title":"Crit Care Lond Engl"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib74","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3904\/kjim.2015.30.4.478","article-title":"Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies","volume":"30","author":"Kang","year":"2015","journal-title":"Korean J Intern Med"},{"issue":"9","key":"10.1016\/j.ejca.2026.116924_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1159\/000489718","article-title":"Extracorporeal Membrane Oxygenation in Predominantly Leuco- and Thrombocytopenic Haematologic\/Oncologic Patients with Acute Respiratory Distress Syndrome - a Single-Centre Experience","volume":"41","author":"Stecher","year":"2018","journal-title":"Oncol Res Treat"},{"issue":"5","key":"10.1016\/j.ejca.2026.116924_bib76","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1097\/CCM.0000000000002293","article-title":"Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome","volume":"45","author":"Wohlfarth","year":"2017","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ejca.2026.116924_bib77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2213-2600(22)00535-5","article-title":"Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement","volume":"11","author":"Di Nardo","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib78","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1164\/rccm.201708-1761OC","article-title":"Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study","volume":"197","author":"Schmidt","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib79","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00134-022-06635-y","article-title":"Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis","volume":"48","author":"Kochanek","year":"2022","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib80","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00134-025-08113-7","article-title":"Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort study","volume":"51","author":"Schellongowski","year":"2025","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib81","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.md.0000145370.63676.fb","article-title":"The Prognosis of Acute Respiratory Failure in Critically Ill Cancer Patients","volume":"83","author":"Azoulay","year":"2004","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-016-0202-0","article-title":"Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en R\u00e9animation Respiratoire en Onco-H\u00e9matologie (Grrr-OH) study","volume":"6","author":"Contejean","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"8","key":"10.1016\/j.ejca.2026.116924_bib83","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.201001-0018OC","article-title":"Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure: Randomized Controlled Trial","volume":"182","author":"Azoulay","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ejca.2026.116924_bib84","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2023021414","article-title":"How I manage acute respiratory failure in patients with hematological malignancies","volume":"143","author":"Azoulay","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib85","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1183\/09031936.00122512","article-title":"Clinical assessment for identifying causes of acute respiratory failure in cancer patients","volume":"42","author":"Schnell","year":"2013","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-2600(18)30345-X","article-title":"Acute respiratory failure in immunocompromised adults","volume":"7","author":"Azoulay","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib87","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Diagnosis of severe respiratory infections in immunocompromised patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib88","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-025-01568-3","article-title":"Significance of positive semi-quantitative PCR tests on bronchoalveolar lavage for Pneumocystis jirovecii pneumonia in HIV-negative immunocompromised ICU patients with acute respiratory failure","volume":"15","author":"Vaconsin","year":"2025","journal-title":"Ann Intensive Care"},{"issue":"12","key":"10.1016\/j.ejca.2026.116924_bib89","first-page":"2006","article-title":"Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en R\u00e9animation Respiratoire en Onco-H\u00e9matologie","volume":"30","author":"Darmon","year":"2015","journal-title":"Nephrol Dial Transplant Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"11","key":"10.1016\/j.ejca.2026.116924_bib90","first-page":"1997","article-title":"Acute kidney injury in critically ill patients with solid tumours","volume":"33","author":"Kemlin","year":"2018","journal-title":"Nephrol Dial Transplant Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"5","key":"10.1016\/j.ejca.2026.116924_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232370","article-title":"Acute kidney injury in critically ill cancer patients is associated with mortality: A retrospective analysis","volume":"15","author":"Seylanova","year":"2020","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib92","first-page":"537","article-title":"Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units","volume":"26","author":"Maccariello","year":"2011","journal-title":"Nephrol Dial Transplant Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib93","doi-asserted-by":"crossref","first-page":"717","DOI":"10.23876\/j.krcp.21.305","article-title":"Hospital mortality and prognostic factors in critically ill patients with acute kidney injury and cancer undergoing continuous renal replacement therapy","volume":"41","author":"Kim","year":"2022","journal-title":"Kidney Res Clin Pract"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178824","article-title":"Neurological failure in ICU patients with hematological malignancies: A prospective cohort study","volume":"12","author":"Marzorati","year":"2017","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib95","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00134-009-1709-8","article-title":"Central neurological complications in critically ill patients with malignancies","volume":"36","author":"Legriel","year":"2010","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib96","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00134-014-3214-y","article-title":"Neurological examination of critically ill patients: a pragmatic approach. Report of an ESICM expert panel","volume":"40","author":"Sharshar","year":"2014","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.ejca.2026.116924_bib97","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ejhf.2017","article-title":"Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology","volume":"22","author":"Pudil","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib98","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ejca.2026.116924_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.713694","article-title":"Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission","volume":"8","author":"Montisci","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ehf2.13734","article-title":"Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry","volume":"9","author":"Delmas","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib101","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCHEARTFAILURE.114.001292","article-title":"Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy","volume":"7","author":"Oliveira","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejca.2026.116924_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154077","article-title":"Characteristics and outcomes of autologous hematopoietic stem cell transplant recipients admitted to intensive care units: A multicenter study","volume":"71","author":"Nassar","year":"2022","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib103","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00277-022-05028-x","article-title":"Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis","volume":"102","author":"Garcia Borrega","year":"2023","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.ejca.2026.116924_bib104","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3109\/10428194.2015.1034700","article-title":"Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma","volume":"56","author":"Kerhuel","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib105","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00277-023-05612-9","article-title":"Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients","volume":"103","author":"Heybati","year":"2024","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.ejca.2026.116924_bib106","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","article-title":"Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data","volume":"45","author":"Darmon","year":"2019","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib107","doi-asserted-by":"crossref","first-page":"110","DOI":"10.56875\/2589-0646.1114","article-title":"Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients","volume":"17","author":"Solaiman","year":"2024","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib108","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41409-018-0181-x","article-title":"Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality","volume":"53","author":"Saillard","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ejca.2026.116924_bib109","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00277-021-04698-3","article-title":"Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital","volume":"101","author":"Garcia Borrega","year":"2022","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.ejca.2026.116924_bib110","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41409-020-0857-x","article-title":"Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score","volume":"55","author":"Pichereau","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.ejca.2026.116924_bib111","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1164\/rccm.202401-0135OC","article-title":"Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients","volume":"210","author":"Lafarge","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ejca.2026.116924_bib112","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2015.55","article-title":"Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients","volume":"50","author":"Lenglin\u00e9","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ejca.2026.116924_bib113","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41409-022-01875-4","article-title":"Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients","volume":"58","author":"Lueck","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib114","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13054-025-05486-5","article-title":"Critical care illness in allogeneic hematopoietic stem-cell transplantation recipients with chronic graft versus host disease","volume":"29","author":"Chean","year":"2025","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.ejca.2026.116924_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.107958","article-title":"Critical care considerations of chimeric antigen receptor (CAR) T-cell therapy","volume":"238","author":"Ponnapalli","year":"2025","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ejca.2026.116924_bib116","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/S2352-3026(21)00060-0","article-title":"Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study","volume":"8","author":"Azoulay","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejca.2026.116924_bib117","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcrc.2020.04.008","article-title":"The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities","volume":"58","author":"Gutierrez","year":"2020","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib118","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-024-01247-9","article-title":"Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort","volume":"14","author":"Le Cacheux","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib119","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"35","key":"10.1016\/j.ejca.2026.116924_bib120","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.21.01992","article-title":"Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline","volume":"39","author":"Santomasso","year":"2021","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2026.116924_bib121","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/bloodadvances.2021004896","article-title":"Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days","volume":"5","author":"Mikkilineni","year":"2021","journal-title":"Blood Adv"},{"issue":"24","key":"10.1016\/j.ejca.2026.116924_bib122","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood.2020010543","article-title":"CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed\/refractory large B-cell lymphoma","volume":"138","author":"Rejeski","year":"2021","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.ejca.2026.116924_bib123","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2026.116924_bib124","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol J Eur Soc Med Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116924_bib125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/qjmed\/hcac258","article-title":"Intensive care unit requirements in patients treated with immune checkpoint inhibitors","volume":"116","author":"Cooksley","year":"2023","journal-title":"QJM Mon J Assoc Physicians"},{"key":"10.1016\/j.ejca.2026.116924_bib126","doi-asserted-by":"crossref","first-page":"k4226","DOI":"10.1136\/bmj.k4226","article-title":"Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis","volume":"363","author":"Xu","year":"2018","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ejca.2026.116924_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7302","article-title":"Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors","volume":"13","author":"Lin","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib128","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-023-01122-z","article-title":"ICU admission for solid cancer patients treated with immune checkpoint inhibitors","volume":"13","author":"Toffart","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.ejca.2026.116924_bib129","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-020-00761-w","article-title":"Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit","volume":"10","author":"Joseph","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ejca.2026.116924_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.932400","article-title":"Cardiogenic shock among cancer patients","volume":"9","author":"Curtiaud","year":"2022","journal-title":"Front Cardiovasc Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:21:56Z","timestamp":1787415716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":130,"alternative-id":["S0959804926007057"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116924","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of critically ill cancer patients. Expert consensus statement of the \u201cIntensive Care for Hematology and Oncology Patients\u201d (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (\u00d6GIAIN)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116924"}}